AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇿🇲
Salbutamol in Zambia
4 products registered with ZAMRA — 4 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| Durasal CR 4 mg Capsules Capsules | 029/011 | RAPTAKOS, BRETT & CO. LTD | active | 14 Jun 2031 |
| Lastmol (Salbutamol 2mg) Syrup Oral Syrup | 309/006 | Laboratory & Allied Ltd | active | 22 Dec 2029 |
| Venteze inhaler Inhalation aerosol | 145/016 | Pharmacare Limited | active | 18 Dec 2029 |
| Salbuvent (Salbutamol 0.5%) Nebulizer | ZAMRA-HM-23-68 | Diamond Pharma | active | 29 Aug 2028 |
Salbutamol — ZAMRA Registration Details
ZAMRA (Zambia) has 4 registered products containing Salbutamol, of which 4 are currently active. Data is sourced directly from the official ZAMRA drug register and refreshed daily.
Track Salbutamol registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.